SCHEDULE: Morgan Stanley Discloses 7% Stake in Evolent Health

Morgan Stanley and its subsidiary have disclosed a 7.0% beneficial ownership stake in Evolent Health, Inc.'s Class A Common Stock, held for passive investment purposes.

Summary

• Morgan Stanley reported beneficial ownership of 8,210,410 shares of Evolent Health, Inc. Class A Common Stock, representing 7.0% of the class.
• Morgan Stanley Capital Services LLC, a wholly-owned subsidiary of Morgan Stanley, reported beneficial ownership of 6,776,898 shares, representing 5.8% of the class.
• The shares are held with shared voting power of 8,202,877 for Morgan Stanley and 6,776,898 for Morgan Stanley Capital Services LLC.
• Shared dispositive power is 8,210,410 for Morgan Stanley and 6,776,898 for Morgan Stanley Capital Services LLC.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: Neutral, as this is a factual disclosure of a passive ownership stake, not a performance report or strategic announcement.

Positives

• A major financial institution, Morgan Stanley, holds a significant 7.0% stake in Evolent Health, Inc., potentially signaling institutional confidence.
• The investment is explicitly stated to be for passive purposes, not intended to influence or change control of the issuer.

Future Outlook

Not applicable. This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from the issuer.

Industry Context

Not applicable. This filing is a disclosure of beneficial ownership and does not provide analysis of broader industry trends or competitors.

Related Party Transactions

• Morgan Stanley is reporting as a parent holding company for securities beneficially owned by its wholly-owned subsidiary, Morgan Stanley Capital Services LLC.

Stakeholder Impact

• Shareholders of Evolent Health, Inc. are informed of a significant passive ownership stake held by a major financial institution, which may be viewed as a positive signal of confidence.
• The disclosure clarifies that the investment is not intended to influence corporate control, providing stability regarding potential activist investor actions.

Key Dates

Keywords

Evolent Health, Morgan Stanley, Schedule 13G, beneficial ownership, Class A Common Stock, institutional ownership, healthcare technology